Zealand Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zealand Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ZEAL

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. 

CEO
Adam Sinding Steensberg, MD, MBA
CEOAdam Sinding Steensberg, MD, MBA
Employees
335
Employees335
Headquarters
Soborg, Zealand
HeadquartersSoborg, Zealand
Founded
1997
Founded1997
Employees
335
Employees335

ZEAL Key Statistics

Market cap
1.24B
Market cap1.24B
Price-Earnings ratio
-4.51
Price-Earnings ratio-4.51
Dividend yield
Dividend yield
Average volume
1.70K
Average volume1.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$32.94
52 Week high$32.94
52 Week low
$9.93
52 Week low$9.93

Stock Snapshot

Zealand Pharma(ZEAL) stock is priced at $17.59, giving the company a market capitalization of 1.24B. It carries a P/E multiple of -4.51.

On 2025-12-08, Zealand Pharma(ZEAL) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Zealand Pharma(ZEAL) stock has reached 0, versus its average volume of 1.7K.

The stock's 52-week range extends from a low of $9.93 to a high of $32.94.

The stock's 52-week range extends from a low of $9.93 to a high of $32.94.

ZEAL News

TipRanks 3d
Zealand Pharma price target lowered to DKK 825 from DKK 850 at Berenberg

Berenberg lowered the firm’s price target on Zealand Pharma (ZLDPF) to DKK 825 from DKK 850 and keeps a Buy rating on the shares. TipRanks Cyber Monday Sale C...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.